Effect of ascorbic acid concentrations on hemodynamics and inflammation following lyophilized plasma transfusion

Journal of Trauma and Acute Care Surgery

Volumn 79, Issue 1, 2015, Pages 30-38

  McCully, Sean P ^a   Martin, David T ^a   Cook, Mackenzie R ^a   Gordon, Nicole T ^a   McCully, Belinda H ^a   Lee, Tim H ^a   Dean, Rondi K ^a   Rick, Elizabeth A ^a   Moren, Alexis M ^a   Fair, Kelly A ^a   Undurraga, Vicente J ^a   Watson, Kathrine M ^a   Anderson, Nathan W ^a   Schreiber, Martin A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

ascorbic acid; dysfunctional inflammation; Lyophilized plasma; swine; trauma

Indexed keywords

ASCORBIC ACID; C REACTIVE PROTEIN; HYDROCHLORIC ACID; INTERLEUKIN 10; INTERLEUKIN 6; PROCOAGULANT; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD CHEMISTRY; CONTROLLED STUDY; DNA DAMAGE; EXPERIMENTAL PIG; FEMALE; HEMODYNAMICS; INFLAMMATION; LIVER INJURY; NONHUMAN; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHOCK; THROMBOELASTOGRAPHY; ANIMAL; BLOOD; BLOOD TRANSFUSION; CHEMISTRY; FREEZE DRYING; PIG; PLASMA;

ANIMALS; ASCORBIC ACID; BLOOD TRANSFUSION; CYTOKINES; DNA DAMAGE; FEMALE; FREEZE DRYING; HEMODYNAMICS; PLASMA; PROSPECTIVE STUDIES; SWINE; THROMBELASTOGRAPHY;

EID: 84935112050     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000684     Document Type: Article

References (32)

1. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208:2581-2590.
2. Spoerke N, Zink K, Cho SD, Differding J, Muller P, Karahan A, Sondeen J, Holcomb JB, Schreiber M. Lyophilized plasma for resuscitation in a swine model of severe injury. Arch Surg. 2009;144:829-834.
3. Lee TH, Watson K, Fabricant L, Barton J, Differding J, Kremenevskiy I, Sands C, Wiles C, Watters JM, Schreiber MA. Hyperosmolar reconstituted lyophilized plasma is an effective low-volume hemostatic resuscitation fluid for trauma. J Trauma Acute Care Surg. 2013;75(3):369-375.
4. Van PY, Hamilton GJ, Kremenevskiy IV, Sambasivan C, Spoerke NJ, Differding JA, Watters JM, Schreiber MA. Lyophilized plasma reconstituted with ascorbic acid suppresses inflammation and oxidative DNA damage. J Trauma. 2011;71:20-24.
5. Hamilton GJ, Van PY, Differding JA, Kremenevskiy IV, Spoerke NJ, Sambasivan C, Watters JM, Schreiber MA. Lyophilized plasma with ascorbic acid decreases inflammation in hemorrhagic shock. J Trauma. 2011;71:292-297.
6. Cho SD, Holcomb JB, Tieu BH, Englehart MS, Morris MS, Karahan ZA, Underwood SA, Muller PJ, Prince MD, Medina L, et al. Reproducibility of an animal model simulating complex combat-related injury in a multiple-institution format. Shock. 2009;31:87-96.
7. Bonsnes R, Taussky H. On the colorimetric determination of creatinine by the Jaffe reaction. J Biol Chem. 1945;158:581-582-591.
8. Meng QH, Irwin WC, Fesser J, Massey KL. Interference of ascorbic acid with chemical analytes. Ann Clin Biochem. 2005;42:475-477.
9. Meng QH, Irwin WC, Visvanathan K. Vitamin C and aberrant electrolyte results. Clin Chem Lab Med. 2005;43:454-456.
10. Lee TH, Van PY, Spoerke NJ, Hamilton GJ, Cho SD, Watson K, Differding J, Schreiber MA. The use of lyophilized plasma in a severe multi-injury pig model. Transfusion. 2013;53(Suppl 1):72S-79S.
11. Lee TH, McCully SP, McCully BH, Sands C, Hampton DA, Louis SG, Rick B, Anderson N, Differding J, Schreiber MA. Comparison of the hemostatic efficacy of low-volume lyophilized plasma reconstituted using sterile water, lactated Ringer's, normal saline, and hextend solutions. J Trauma Acute Care Surg. 2014;76:264-271.
12. Wilson JX, Wu F. Vitamin C in sepsis. Subcell Biochem. 2012;56:67-83.
13. Biesalski HK, McGregor GP. Antioxidant therapy in critical care - is the microcirculation the primary target? Crit Care Med. 2007;35:S577-S583.
14. Long CL, Maull KI, Krishnan RS, Laws HL, Geiger JW, Borghesi L, Franks W, Lawson TC, Sauberlich HE. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res. 2003;109:144-148.
15. Heyland DK, Dhaliwal R, Day AG, Muscedere J, Drover J, Suchner U, Cook D, Canadian Critical Care Trials Group. REducing deaths due to OXidative stress (the REDOXS study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc. 2006;65:250-263.
16. Rumelin A, Humbert T, Luhker O, Drescher A, Fauth U. Metabolic clearance of the antioxidant ascorbic acid in surgical patients. J Surg Res. 2005;129:46-51.
17. Crandon JH, Landau B, Mikal S, Balmanno J, Jefferson M, Mahoney N. Ascorbic acid economy in surgical patients as indicated by blood ascorbic acid levels. N Engl J Med. 1958;258:105-113.
18. Levenson SM, Green RW, Taylor FH, Robinson P, Page RC, Johnson RE, Lund CC. Ascorbic acid, riboflavin, thiamin, and nicotinic acid in relation to severe injury, hemorrhage, and infection in the human. Ann Surg. 1946;124:840-856.
19. Schorah CJ, Downing C, Piripitsi A, Gallivan L, Al-Hazaa AH, Sanderson MJ, Bodenham A. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr. 1996;63:760-765.
20. Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, Radella F, Garcia I, Maier RV. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg. 2002;236:814-822.
21. Tanaka H, Matsuda T, Miyagantani Y, Yukioka T, Matsuda H, Shimazaki S. Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study. Arch Surg. 2000;135:326-331.
22. Cohen MJ, Kutcher M, Redick B, Nelson M, Call M, Knudson MM, Schreiber MA, Bulger EM, Muskat P, Alarcon LH, et al. Clinical and mechanistic drivers of acute traumatic coagulopathy. J Trauma Acute Care Surg. 2013;75(1 Suppl 1):S40-S47.
23. Cohen MJ, West M. Acute traumatic coagulopathy: from endogenous acute coagulopathy to systemic acquired coagulopathy and back. J Trauma. 2011;70:S47-S49.
24. Cohen MJ, Call MF, Nelson M, Fau C, Carolyn S, Fau CC, Fau EC, Brohi KF, Pittet JF. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg. 2012;255(2):379-385.
25. Berger MM. Antioxidant micronutrients in major trauma and burns: evidence and practice. Nutr Clin Pract. 2006;21:438-449.
26. Berger MM, Soguel L, Shenkin A, Revelly JP, Pinget C, Baines M, Chiolero RL. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit Care. 2008;12:R101.
27. Bulger EM, Maier RV. Antioxidants in critical illness. Arch Surg. 2001;136:1201-1207.
28. Crimi E, Sica V, Williams-Ignarro S, Zhang H, Slutsky AS, Ignarro LJ, Napoli C. The role of oxidative stress in adult critical care. Free Radic Biol Med. 2006;40:398-406.
29. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med. 1995;23:646-651.
30. Fowler AA 3rd, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, Farthing CA, Larus TL, Martin E, Brophy DF, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12:32.
31. Maxwell RA, Gibson JB, Fabian TC, Proctor KG. Effects of a novel antioxidant during resuscitation from severe blunt chest trauma. Shock. 2000;14:646-651.
32. Gokce M, Saydam O, Hanci V, Can M, Bahadir B. Antioxidant vitamins C, E and coenzyme Q10 vs dexamethasone: comparisons of their effects in pulmonary contusion model. J Cardiothorac Surg. 2012;7:92.